Jianying Zhang is currently working as Professor and Director at Cancer Autoimmunity and Cancer Epidemiology Research Lab, Department of Biological Sciences & NIH-Sponsored Border Biomedical Research Center (BBRC), The University of Texas, El Paso, Texas. He has done his Ph.D. on Tumor Molecular Biology and Tumor Immunology from Xiamen University. He then joined as Lecturer & Assistant Professor at Zhengzhou University Medical School, China. He has done his Postdoctoral Research Fellow and Research Associate Scientist at W.K. Autoimmune Disease Center, Department of Molecular & Experimental Medicine, The Scripps Research Institute, La Jolla, California. He is a Peer Reviewer for various Scientific Journals like British Journal of Cancer, BMC Cancer, Clinical Cancer Research, Cancer Letters, Clinical Immunology, Cancer Detection and Prevention, Cancer Research etc.
Dr. Han is currently working as Assistant Professor at Stanford University School of Medicine. She received her Ph.D. on Statistics from Yale University focusing on statistical genetics. After completing her Ph.D., Dr. Han trained as Research Fellow in the Biostatistics Branch of the Division of Cancer Epidemiology & Genetics at the National Cancer Institute, USA, where she developed several novel statistical methods to identify genetic and environmental risk factors for cancer. Dr. Han has authored several publications in various journals and books related to cancer epidemiology and screening. Her publications reflect her research interests in cancer genetic epidemiology and lung cancer screening. Dr. Han is also a Statistical Editor of the Journal of the National Cancer Institute. Dr. Han is currently in charge of ongoing scholarly project for evaluating genetic, clinical, and environmental risk factors for second primary lung cancer to establish effective screening strategies for lung cancer survivors. Dr. Han is recently awarded by the NIH R01 grant.
Dr. Han's research focuses on understanding the genetic and environmental etiology of complex disease and developing and evaluating efficient screening strategies based on etiological understanding. The areas of her research interests include statistical genetics, molecular epidemiology, cancer screening, health policy modeling, and risk prediction modeling.
Coombes is a world-leading breast cancer expert at Imperial College London and director of the Cancer Research UK Imperial Centre. Along with his team, he is studying how some breast cancers become resistant to hormone therapies by investigating key molecules in the cells. He is using this knowledge to develop and test new breast cancer drugs. This kind of research is urgently needed to give thousands of women whose breast cancer stops responding to hormone therapies more options and more tomorrows.
Vessela Vassileva completed her Hon. BSc in Human Biology, MSc in Cancer Genetics, and PhD in Pharmaceutical Sciences at the University of Toronto. She completed postdoctoral studies at the Barts Cancer Institute, where she worked on several pre-clinical and clinical projects focused on targeting cancer-related inflammation and combination therapies for ovarian cancer.
Currently, she is working on various cancer pharmacology and molecular imaging projects, involving the discovery and development of new methods for experimental and clinical imaging of cancer. She also works on therapeutic strategies that target the tumour microenvironment, the optimisation of radio immunotherapy, rational combination therapies, and the development of theranostic strategies for the detection and treatment of solid tumours.
Sophie D. Fossa is currently working as senior researcher at the University of Oslo, Norway. She received her Doctoral degree on bladder cancer from the University of Oslo in 1977 She then worked at Oslo University Hospital, Radium hospital as clinical oncologist being a Professor at the University in Oslo since 1992. She has authored /co-authored about 750 publications in various journals and books. Her publications reflect his research interests in Uro-oncology and long-term cancer survivorship. She is a member of ASCO. She is currently in charge of on-going scholarly projects in prostate and testicular cancer and cancer survivorship.
Survival after prostate cancer, based on Data from the Cancer registry of Norway. Long-term adverse effects after testicular cancer. Quality of Life after pediatric and adolescent cancer.
Antonios Drevelegas received his Medical Degree with the Specialty of Radiology and his Ph.D. degree in 1972 and 1981, respectively, both from the Medical School of Aristotle University of Thessaloniki (AUTH). He took the position of Assistant Professor, Associate Professor and Professor in 1998, 2003 and 2008, respectively, in the Radiology Department of AUTH. He is an active member of the Radiological Society of North America, the Cardiovascular and Interventional Radiological Society of Europe and the European Association of Radiology (EAR). He is currently chairman at the Radiology Dept. of Aristotles University of Thessaloniki.
His research interests include advanced MRI techniques, invasive radiology and oncology.
Kazunari K. Yokoyama is a professor of Kaohsiung Medical University in Taiwan. He completed his Ph.D. at University of Tokyo, Department of Science, Division of Biophysics and Biochemistry (1979). He worked at Albert Einstein College of Medicine (1979-1983) in USA, to involve in the structural study of mouse MHC class I protein, and Backman Research Institute of City of Hope (1983-1985) in USA as a junior research scientist to study the liver regeneration and carcinogenesis, and got a job at RIKEN Institute (1985 -2009) in Japan at 1985, as the Head of DNA Bank to involve in the study of antisense RNA against c-Myc oncogene, and RIKEN human genome project in Japan. During this period, I went to Pasteur Institute (1990) in France to cooperate the project of MHC class 1 gene regulation by adenovirus E1A. Then, he moved to Kaohsiung Medical University (2009) in Taiwan from RIKEN at 2009. He has published more than 270 papers including Nature, Science, Nature Genetics, Molecular Cell, Genes & Development, Nature Structural Molecular Biology, EMBO J, Immunity, and Proc Natl Acad Sci USA (see http://kazu.dlearn.kmu.edu.tw) and a serving as peer reviewer of Japanese International Awards of Sciences, Japan Awards and member of American Association for Cancer Research, American Society for Microbiology and International Stem Cell Research.
(1). Chromatin control of transcription factor JDP2 in phase I and Phase II enzyme network and ROS regulation
(2). Cancer stem cells and human gene therapy for cancer prevention
Milan Stankovic was born in 1959. He finished medical Studies as the best in the class. Later on he achieved his Specialization in Otolaryngology in Nis, and Ph. D. in Belgrade. He had education in Otolaryngology Clinics in Basel, Zurich, Geneve, Vienna, Berlin, Tokyo, Osaka, etc. He is currently: Full time Professor of Otolaryngology, Head of Otolaryngology at Medical Faculty University of Nis Serbia, Instructor of European Academy of Otology and Otoneurology, Ambassador to American Academy of Otolaryngology, Visiting Professor at Ahepa University Hospital Thessaloniki, Greece, International Elector at Ahepa University Hospital Thessaloniki, and Larisa University of Thessaly, Greece, Honorary Member of Italian Rhinologic Society, Honorary Member of ENT Society of Northern Greece, Contributor to Encyclopedia of ORL, Springer, New York, Editor in World Articles of Otolaryngology, Member of Editorial Board for International Advanced Otology, Balkan Journal of Medicine, Journal of Hearing Science. He was: President of Balkan Society of Otolaryngology, Board Member of Balkan ORL Society, Vice President of Serbian ORL Society, and Regional Secretary of European Academy of Otology and Otoneurology, Full time Professor University of Podgorica-Montenegro, University of Banja Luka-Bosnia, University of Stip-Macedonia.
Head and Neck Oncology, Skull Base Surgery, Otology and Otoneurology.
She completed her secondary education at Izmir 60th Year Anatolian High School and Izmir Science High School. In 1996, she entered Hacettepe University Faculty of Medicine. After completing 6 years medical faculty education, she received Medical Doctor title in 2002. In 2004, she started to specialize in Radiology Department of Radiology Department of Izmir Education and Research Hospital and became Radiology Expert in 2010. In 2010-2011, she performed his mandatory service duty as Akcakale State Hospital's Radiology Specialist. Between 2011 and 2014, she worked at Baskent University Adana Hospital Interventional Radiology Department. In 2014-2015 she worked as an Interventional Radiology Specialist in Medicana Camlica Hospital. Shuan Acibadem University Atakent Hospital is working as an interventional radiology specialist.